News

Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists

In Vitro Diagnostic Device Designed for Dried Blood Spot Analysis Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists October 10, 2018 08:00 AM Eastern Daylight Time MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) introduced the RenataDX™ Screening System, a flow-injection tandem mass spectrometry (FIA-MS/MS) system for rapid high-throughput analysis of extracted dried blood spots…
Read more...

The Historical Role of Mass Spectrometry in Newborn Screening

From the Guthrie Test to a unique technology collaboration Newborn screening for inherited metabolic disorders dates to the early 1960s, when Dr. Robert Guthrie in Buffalo, New York developed the first screening test for phenylketonuria (or PKU), a metabolic disease in which patients can’t metabolize the amino acid phenylalanine. The so-called “Guthrie Test” was simple,…
Read more...

Food safety analysis using QuEChERS, LC-MS/MS and GC-MS/MS

Separation Science, in collaboration with Waters, offers a selection of presentations and resources demonstrating effective methods for food safety analysis using QuEChERS, LC-MS/MS and GC-MS/MS. The benefits of using the Xevo TQ-GC and Xevo TQ-S Miro in such applications is shown. View the presentations from the two experts below and download the resources to see…
Read more...

Introducing Illumina Ampliseq On-demand custom panels

Create amplicon panels with the genes you want. AmpliSeq for Illumina On Demand panels provide a choice of > 5000 pretested genes with known content relevant for inherited disease research, including hereditary cancer, primary immunodeficiency, hearing loss, and muscular dystrophy. AmpliSeq chemistry and Illumina next-generation sequencing (NGS) technology provide unmatched data quality, even from low-quality…
Read more...

Illumina Day, May 15-16, Kyiv, UNIT City

Illumina day in Kyiv is an event focused on next generation sequencing with the emphasis on its use for diagnostic and basic research purpose in medicine and biology, llumina Day will take place at UNIT.City on May 15-16. Our keynote speaker, Prof. Rafał Płoski (Poland), as well Illumina's Ukrainian customers will share their NGS experience and success…
Read more...

Illumina passed its forensic portfolio to Verogen

Starting of 2018,  products and solutions for forensic genetics and human identification will be supplied by Verogen. This company has taken over all the relevant Illumina portfolio based on NGS using the MiSeq FGx system,  ForenSeq DNA Signature Prep Kit, and ForenSeq Universal Analysis Software program, for genomic DNA sampling. At the same time, for the…
Read more...

Introducing AmpliSeq™ for Illumina®

AmpliSeq for Illumina is a suite of AmpliSeq chemistry products that are compatible with Illumina next-generation sequencing platforms. The AmpliSeq for Illumina solution offers a highly multiplexed polymerase chain reaction (PCR)-based workflow for use with targets ranging from a few to hundreds in a single run. Combined with Illumina next-generation sequencing (NGS) technology, AmpliSeq for…
Read more...

IMG Ltd. will take part in the conference Integrative Biology and Medicine

IMG Ltd, an Illumina channel partner in Ukraine, will take part in the conference Integrative Biology and Medicine which will be held on Oct 2-7 at the Hall of the National Academy of Sciences, Kyiv, Ukraine. The main focus is genomics, bioinformatics, translational medicine, evolution. We will make two presentations on Illumina solutions for oncogenetics (Oct…
Read more...